Neuronetics, Inc. (NASDAQ: STIM) has reported its financial and operational results for the third quarter of 2024, amid ...

JMP Securities analyst Daniel Stauder reiterated a Buy rating on Neuronetics (STIM – Research Report) today and set a price target of ...

On November 8, 2024, Neuronetics (STIM)’ stockholders approved the previously announced acquisition of Greenbrook TMS in which ...

商业化阶段医疗技术公司Neuronetics, Inc. (NASDAQ: STIM)在其2024年第三季度财报电话会议上报告了收入增长,由首席执行官Keith Sullivan主持。与去年同期相比,公司总收入增长4%至1850万美元,治疗会话收入攀升至1330万美元。Greenbrook TMS的收购预计将在2024年第四季度完成,预期成本协同效应现在预计为2000万美元。Neuronetics ...

Greenbrook TMS (NASDAQ:GBNH) stock is rocketing higher on Wednesday alongside heavy trading of the operator of mental health services centers’ shares this morning. As of this writing ...

总部位于宾夕法尼亚州马尔文的医疗技术公司Neuronetics, Inc. (NASDAQ:STIM)今天宣布修订与Madryn Asset Management LP的注册权协议,将Madryn要求注册其股份的期限从180天延长至365天。这一调整将要求注册期从与Greenbrook TMS Inc.完成安排协议后的180天延长至365天。

MALVERN, Pa. and TORONTO, Oct. 4, 2024 /CNW/ - Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today ...

Greenbrook TMS Inc. (OTC: GBNHF) (" Greenbrook " or the " Company ") is pleased to announce the voting results from its special meeting of sharehol ...

MALVERN, Pa. and TORONTO, Oct. 4, 2024 /PRNewswire/ - Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today announced that the Ontario Superior ...

Neuronetics, Inc. (NASDAQ: STIM ) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today announced that the Ontario Superior Court of Justice ...

TORONTO - Greenbrook TMS Inc. (NASDAQ: GBNH), a provider of Transcranial Magnetic Stimulation (TMS) therapy for depression, is set to be delisted from the Nasdaq Stock Market on ...

Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today announced that the Ontario Superior Court of Justice ...